BCRX fund manager activity
BioCryst Pharmaceuticals, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2015 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 2,604,027 | $26,040,270 | 0.01% | Aug 4, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 156,421 | $1,564,210 | 0.00% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Added | 2,733,253 | $26,020,567 | 0.01% | May 5, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 312,961 | $2,979,389 | 0.01% | May 15, 2026 |